GDP | MHRA

Total Records 1551 to 1560 of 2802

GDP Search Results
Certificate Number	Site Details	Country	Inspection Date
UK WDA(H) 53331 Insp GDP 53331/15388984-0002	PLUTUS HEALTHCARE LIMITED, 20 MORTLAKE HIGH STREET, LONDON, SW14 8JN, UNITED KINGDOM	UNITED KINGDOM	10/10/2019
UK WDA(H) 43557 Insp GDP 43557/16147675-0003	DCS GROUP (UK) LIMITED, OCEAN HOUSE, NORAL WAY, BANBURY, OX16 2AA, UNITED KINGDOM	UNITED KINGDOM	10/10/2019
UK WDA(H) 19635 Insp GDP 19635/358236-0007	CNX THERAPEUTICS LIMITED, FIRST FLOOR, SOUTHSIDE, 97-105 VICTORIA STREET, LONDON, SW1E 6QT, UNITED KINGDOM	UNITED KINGDOM	10/10/2019
UK WDA(H) 25057 Insp GDP 25057/17818392-0004	CLEAR PHARMACY, BLOCK D, 17 HERON ROAD, BELFAST, BT3 9LE, UNITED KINGDOM	UNITED KINGDOM	09/10/2019
UK WDA(H) 12854 Insp GDP 12854/3426-0007	CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST - CENTRAL PHARMACY DEPT, CENTRAL PHARMACY, ADDENBROOKES HOSPITAL, HILLS ROAD, CAMBRIDGE, CB2 2QQ, UNITED KINGDOM	UNITED KINGDOM	08/10/2019
UK WDA(H) 51638 Insp GDP 51638/18903065-0001	CBD ROEVALLEY LTD, 16 CROSSNADONNELL ROAD, LIMAVADY, BT49 0BD, UNITED KINGDOM	UNITED KINGDOM	07/10/2019
UK WDA(H) 49243 Insp GDP 49243/18233454-0002	SUPER HAPPY WING LIMITED, 37B GOLF ROAD, DEAL, CT14 6PY, UNITED KINGDOM	UNITED KINGDOM	26/09/2019
UK WDA(H) 42177 Insp GDP 42177/7821365-0005	FIRSTLINE PHARMA LTD, 54 LONG CHAULDEN, HEMEL HEMPSTEAD, HP1 2HX, UNITED KINGDOM	UNITED KINGDOM	25/09/2019
UK WDA(H) 50026 Insp GDP 50026/18920085-0001	NKLA HEALTHCARE LIMITED, PHARMACY UNIT, 11 THE GREEN, ROWLAND'S CASTLE, PO9 6BW, UNITED KINGDOM	UNITED KINGDOM	24/09/2019

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX